HumeCare+ vs LTTL: Protocols, Pricing, and Tracking Compared
Quick verdict: HumeCare+ vs LTTL
The HumeCare+ vs LTTL choice comes down to protocol depth versus straightforward compounded dosing. HumeCare+ bundles physician-prescribed semaglutide from $199/month or tirzepatide protocols from $299/month with glycine, B6 and B12 plus monthly body composition scans and a 10% or your money back promise over six months. LTTL emphasizes full-dose compounded GLP-1 delivered from U.S. licensed pharmacies with pricing offers including up to $140 off your first month. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Explore HumeCare+ plans starting at $199/mo
Price and promotion comparison
HumeCare+ lists semaglutide starting at $199/month and a tirzepatide protocol from $299/month. LTTL shows promotional pricing with up to $140 off your first month and references prices such as $249 and $129 in captured materials. HumeCare+ notes pricing shown reflects a promotional discount that may change. LTTL’s landing capture emphasizes an auto-applied code for first-month savings.
Protocol components and support
HumeCare+ sells a bundled protocol not just a prescription. Its protocol pairs physician-prescribed compounded semaglutide or tirzepatide with glycine and vitamins B6 and B12, a dedicated app, and continuous clinician access. HumeCare+ positions glycine and B vitamins as muscle-preserving and side-effect support built into the formulation. LTTL focuses on delivering full-dose compounded GLP-1 medications intended to help regulate appetite and fullness. LTTL materials captured do not document added supportive ingredients or an app in the same way.
Distinctive difference 1: muscle support and tracking
HumeCare+ includes monthly body composition scans that track lean mass versus fat, and it states it tracks lean mass not just weight. LTTL’s captured materials do not show an equivalent body-composition tracking feature.
Distinctive difference 2: money-back promise and member claims
HumeCare+ advertises a 10% or your money back promise over six months with terms to verify eligibility. HumeCare+ also cites internal analysis of member results. LTTL’s captured materials do not show a comparable refund promise in the captured content.
Distinctive difference 3: pharmacy verification and dosing consistency
LTTL states medications are compounded by U.S. licensed pharmacies and prepared for delivery with independent verification and confirmations every 3 to 6 months to stay within plus or minus 10 percent of target strength. HumeCare+ also offers compounded medications dispensed from U.S. pharmacies but includes a regulatory note that compounded medications are not FDA-evaluated for safety, quality, or efficacy.
Clinician access, delivery, and logistics
HumeCare+ emphasizes unlimited clinician access, a U.S. care team available 24/7, free next-day delivery, and cancel anytime terms in captured content. LTTL highlights delivery from state-licensed pharmacies and emphasizes on time delivery and independent lab verification in captured content. Both require a licensed clinician to determine medical appropriateness and both use compounded medication language that notes the lack of FDA review.
| Criteria | HumeCare+ | LTTL |
|---|---|---|
| Starting price | Semaglutide from $199/month; tirzepatide protocol from $299/month | Promotions include up to $140 off your first month; captured prices include $249 and $129 |
| Protocol components | GLP-1 plus glycine, B6 and B12, app, body-composition scans | Compounded GLP-1 full-dose; captured content does not show added glycine or vitamins |
| Tracking and scans | Monthly body composition scans tracking lean mass | No body-composition scan documented in captured materials |
| Clinician access | Unlimited clinician access; U.S. care team 24/7 | Clinician-reviewed treatment; capture recommends confirming eligibility and terms |
| Refunds and guarantees | 10% or your money back promise over six months, terms apply | No comparable refund promise captured |
| Regulatory note | Compounded medications are not FDA-approved or reviewed | Compounded medications are not FDA-approved or reviewed |
See LTTL pricing and first-month offer
Safety and regulatory language to note
Both captures state compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Treatment is available only when a licensed clinician determines it is medically appropriate. HumeCare+ also notes compounded medications are not FDA-evaluated for safety, quality, or efficacy and flags that GLP-1 drugs carry serious risks.
Compare HumeCare+ features and clinician access
Which to choose: HumeCare+ vs LTTL
Choose HumeCare+ if you want a bundled protocol that includes physician-prescribed compounded semaglutide or tirzepatide plus glycine and vitamins B6 and B12, monthly body-composition scans, continuous clinician access, and a stated 10% or your money back promise over six months. Choose LTTL if you prioritize straightforward full-dose compounded GLP-1 delivery from U.S. licensed pharmacies with independent lab verification and promotional first-month savings such as up to $140 off. Remember that compounded medications are not FDA-approved and both providers say treatment is subject to clinician review.
Review LTTL eligibility and delivery details
Start with HumeCare+ plans and scans
Primary keyword: HumeCare+ vs LTTL